Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
416.92
+1.71 (0.41%)
Aug 17, 2026, 1:31 PM EDT - Market open
Amgen Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 38,095 | 36,751 | 33,424 | 28,190 | 26,323 | 25,979 |
Revenue Growth | 9.10% | 9.95% | 18.57% | 7.09% | 1.32% | 2.18% |
Gross Profit Gross Profit Growth | 27,387 | 26,014 | 22,966 | 20,395 | 19,947 | 19,525 |
Operating Income Operating Income Growth | 12,725 | 11,574 | 9,676 | 9,823 | 10,098 | 9,151 |
Net Income Net Income Growth | 8,743 | 7,711 | 4,090 | 6,717 | 6,552 | 5,893 |
Earnings Per Share EPS Growth | 16.09 | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 |
EPS Growth | 31.60% | 88.23% | -39.47% | 3.14% | 17.80% | -16.49% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Prolia Prolia Growth | 3,679 | 4,414 | 4,374 | 4,048 | 3,628 | 3,248 |
ENBREL ENBREL Growth | 2,012 | 2,226 | 3,316 | 3,697 | 4,117 | 4,465 |
XGEVA XGEVA Growth | 1,749 | 2,084 | 2,225 | 2,112 | 2,014 | 2,018 |
Repatha Repatha Growth | 3,493 | 3,016 | 2,222 | 1,635 | 1,296 | 1,117 |
Otezla Otezla Growth | 2,132 | 2,265 | 2,126 | 2,188 | 2,288 | 2,249 |
TEPEZZA TEPEZZA Growth | 2,083 | 1,903 | 1,851 | 448 | - | - |
EVENITY EVENITY Growth | 2,416 | 2,100 | 1,563 | 1,160 | 787 | 530 |
KYPROLIS KYPROLIS Growth | 1,354 | 1,412 | 1,503 | 1,403 | 1,247 | 1,108 |
Nplate Nplate Growth | 1,684 | 1,524 | 1,456 | 1,477 | 1,307 | 1,027 |
Aranesp Aranesp Growth | 1,353 | 1,389 | 1,342 | 1,362 | 1,421 | 1,480 |
BLINCYTO BLINCYTO Growth | 1,692 | 1,559 | 1,216 | 861 | 583 | 472 |
KRYSTEXXA KRYSTEXXA Growth | 1,410 | 1,340 | 1,185 | 272 | - | - |
Vectibix Vectibix Growth | 1,228 | 1,175 | 1,045 | 984 | 893 | 873 |
TEZSPIRE TEZSPIRE Growth | 1,680 | 1,478 | 972 | 567 | 170 | - |
Other Products Other Products Growth | 8,294 | 7,263 | 5,630 | 4,696 | 5,050 | 5,710 |
Other Other Growth | 1,836 | 1,603 | 1,398 | 1,280 | 1,522 | 1,682 |
Revenue (Total) Revenue (Total) Growth | 38,095 | 36,751 | 33,424 | 28,190 | 26,323 | 25,979 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13,989 | 9,129 | 11,973 | 10,944 | 9,305 | 8,037 |
Total Debt Total Debt Growth | 57,304 | 55,435 | 60,879 | 65,423 | 39,640 | 33,979 |
Net Cash (Debt) Net Cash Growth | -43,315 | -46,306 | -48,906 | -54,479 | -30,335 | -25,942 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -79.70 | -85.44 | -90.40 | -101.26 | -56.07 | -45.27 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 12,478 | 9,958 | 11,490 | 8,471 | 9,721 | 9,261 |
Capital Expenditures CapEx Growth | -2,303 | -1,858 | -1,096 | -1,112 | -936 | -880 |
Free Cash Flow Free Cash Flow Growth | 10,175 | 8,100 | 10,394 | 7,359 | 8,785 | 8,381 |
Free Cash Flow Growth | -4.06% | -22.07% | 41.24% | -16.23% | 4.82% | -15.25% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.89% | 70.78% | 68.71% | 72.35% | 75.78% | 75.16% |
Operating Margin | 33.40% | 31.49% | 28.95% | 34.85% | 38.36% | 35.23% |
Pretax Margin | 27.00% | 24.42% | 13.79% | 27.86% | 27.91% | 25.79% |
Profit Margin | 22.95% | 20.98% | 12.24% | 23.83% | 24.89% | 22.68% |
FCF Margin | 26.71% | 22.04% | 31.10% | 26.11% | 33.37% | 32.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 10.080 | 9.520 | 9.000 | 8.520 | 7.760 | 7.040 |
Dividend Per Share Growth | 5.86% | 5.78% | 5.63% | 9.79% | 10.23% | 10.00% |
Dividend Yield | 2.42% | 2.95% | 3.62% | 3.19% | 3.30% | 3.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.80 | 22.86 | 34.26 | 22.95 | 21.39 | 21.50 |
Forward PE | 17.73 | 15.46 | 12.59 | 14.95 | 14.40 | 13.06 |
P/FCF Ratio | 22.17 | 21.76 | 13.48 | 20.95 | 15.95 | 15.12 |
PS Ratio | 5.92 | 4.80 | 4.19 | 5.47 | 5.32 | 4.88 |